OCULAR THERAPEUTIX, INC (OCUL) Net Income (Loss) Attributable to Parent USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ocular Therapeutix, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2024.
  • Ocular Therapeutix, Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$64.8 M, a 114% decline year-over-year.
  • Ocular Therapeutix, Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$115 M, a 29.8% decline year-over-year.
  • Ocular Therapeutix, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$80.7 M, a 13.7% decline from 2022.
  • Ocular Therapeutix, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$71 M, a 984% decline from 2021.
  • Ocular Therapeutix, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$6.55 M, a 95.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$115 M -$64.8 M -$34.5 M -114% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$80.7 M -$29.2 M -$13.7 M -88% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$67.1 M -$516 K +$23.7 M +97.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$90.7 M -$20.7 M -$1.92 M -10.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-07
Q1 2023 -$88.8 M -$30.3 M -$17.8 M -142% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$71 M -$15.5 M -$11.7 M -304% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$59.3 M -$24.2 M -$26.8 M -1010% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$32.5 M -$18.8 M -$10.3 M -121% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$22.2 M -$12.5 M -$15.7 M -502% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$6.55 M -$3.85 M +$81.8 M +95.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 -$88.3 M $2.66 M +$14.6 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$103 M -$8.48 M +$28.1 M +76.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$131 M $3.12 M +$24.6 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$156 M -$85.6 M -$59.6 M -229% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$96 M -$11.9 M +$6.83 M +36.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$103 M -$36.6 M -$12.1 M -49.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$90.8 M -$21.5 M -$4.39 M -25.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$86.4 M -$26 M -$8.62 M -49.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$77.8 M -$18.8 M -$3.77 M -25.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$74 M -$24.5 M -$10.6 M -77.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$63.3 M -$17.1 M -$3.36 M -24.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$60 M -$17.4 M -$4.3 M -32.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$55.7 M -$15 M +$557 K +3.58% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$56.2 M -$13.8 M +$4.89 M +26.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$61.1 M -$13.8 M +$2.26 M +14.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$63.4 M -$13.1 M -$280 K -2.18% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$63.1 M -$15.6 M -$5.97 M -62.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$57.1 M -$18.7 M -$7.25 M -63.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$49.9 M -$16 M -$5.18 M -47.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$44.7 M -$12.8 M -$2.19 M -20.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$42.5 M -$9.6 M +$1.93 M +16.7% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$44.4 M -$11.4 M -$1.44 M -14.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$43 M -$10.8 M -$3.26 M -43% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$39.7 M -$10.6 M -$2.68 M -33.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$37.1 M -$11.5 M -$4.23 M -58% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$32.8 M -$10 M -$3.62 M -56.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$29.2 M -$7.58 M -$570 K -8.13% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$28.6 M -$7.95 M -$4.45 M -127% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$24.2 M -$7.29 M -$3.77 M -107% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$20.4 M -$6.39 M -$3.3 M -107% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$17.1 M -$7.01 M -$3.81 M -119% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$13.3 M -$3.51 M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-20
Q3 2013 -$3.52 M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-20
Q2 2013 -$3.09 M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-20
Q1 2013 -$3.2 M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.